
Articles
-
5 days ago |
cfo.com | Lauren Muskett |Adam Zaki
This audio is auto-generated. Please let us know if you have feedback. The Trial Balance is CFO.com’s weekly preview of stories, stats and events to help you prepare. Last week, a Senate parliamentarian blocked a Republican-led effort to eliminate the PCAOB through the budget reconciliation process, ruling that a provision in the “One Big Beautiful Bill Act” to defund the audit regulator and shift its responsibilities to the SEC is a policy change and not a budget matter.
-
1 week ago |
cfo.com | Adam Zaki
This audio is auto-generated. Please let us know if you have feedback. In his second federal indictment in two years, federal prosecutors allege Anosh Ahmed, the former CFO and COO of Loretto Hospital, a 122-bed safety-net hospital on Chicago’s West Side, perpetuated a $290 million fraudulent billing scheme by using stolen patient information to submit fake COVID-19 testing claims to the federal government.
-
1 week ago |
cfo.com | Adam Zaki
This audio is auto-generated. Please let us know if you have feedback. Though data has shown CFOs have been both confident and concerned about the U.S. economic outlook this year, new data from Grant Thornton’s Q2 2025 CFO survey reveals a troubling trend among finance leaders. Amid inflation concerns, tariff uncertainty and weakening consumer demand due to a variety of reasons, profit expectations saw the sharpest decline QoQ in more than three years.
-
1 week ago |
cfo.com | Adam Zaki
This audio is auto-generated. Please let us know if you have feedback. Just like their larger competitors, small and mid-sized businesses are eager to modernize, but turning bold intentions around technology into execution is proving harder than expected.
-
1 week ago |
cfo.com | Lauren Muskett |Adam Zaki
This audio is auto-generated. Please let us know if you have feedback. The Trial Balance is CFO.com’s weekly preview of stories, stats and events to help you prepare. At the Goldman Sachs 46th Annual Global Healthcare Conference last week, Eli Lilly's CFO Lucas Montarce said that a condition of the company’s partnerships with telehealth firms is that they don’t compound drugs like tirzepatide, the active ingredient in Lilly’s weight-loss blockbuster drug Zepbound.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- Yes

RT @ProtonOgun: @JillMalandrino @TradeTalks @ZachNunn @BonifiiOfficial @MarshallHayner @MetallicusTDBN @adamzakinyc of @cfo did a phenomena…

RT @stanfordNYC: Help me out. What could go wrong with electing a 33 year old socialist who has never held a real job or any kind of execut…

RT @Noahpinion: Every time NYC elects a guy like this, it gets exactly what it asked for